Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-09 5:37 pm Purchase | 2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX | Vivo Opportunity Fund Holdings L.P. | 600,157 5.500% | 600,157 (New Position) | Filing History |
| 2024-11-21 4:51 pm Purchase | 2024-11-19 | 13G | Aclaris Therapeutics, Inc. ACRS | Vivo Opportunity Fund Holdings L.P. | 7,955,160 7.400% | 7,955,160 (New Position) | Filing History |
| 2024-11-14 7:02 pm Sale | 2024-09-30 | 13G | Delcath Systems, Inc. DCTH | Vivo Opportunity Fund Holdings L.P. | 1,708,579 5.300% | -1,000,000 (-36.92%) | Filing History |
| 2024-11-14 7:01 pm Purchase | 2024-10-09 | 13G | Unicycive Therapeutics, Inc. UNCY | Vivo Opportunity Fund Holdings L.P. | 60,961,729 9.990% | 1,000,000 (+1.67%) | Filing History |
| 2024-11-14 6:59 pm Sale | 2024-09-30 | 13G | Rezolute, Inc. RZLT | Vivo Opportunity Fund Holdings L.P. | 2,797,704 4.800% | -445,138 (-13.73%) | Filing History |
| 2024-11-14 6:57 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | Vivo Opportunity Fund Holdings L.P. | 218,895 1.100% | 218,895 (New Position) | Filing History |
| 2024-09-05 6:37 pm Sale | 2024-08-27 | 13G | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings L.P. | 6,291,851 16.200% | -1,025,000 (-14.01%) | Filing History |
| 2024-08-14 6:47 pm Purchase | 2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX | Vivo Opportunity Fund Holdings L.P. | 6,249,990 9.990% | 6,249,990 (New Position) | Filing History |
| 2024-05-01 1:07 pm Sale | 2024-04-29 | 13D | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings L.P. | 7,316,851 22.500% | -1,101,242 (-13.08%) | Filing History |
| 2024-03-20 4:30 pm Purchase | 2024-03-14 | 13G | Regulus Therapeutics Inc. RGLS | Vivo Opportunity Fund Holdings L.P. | 5,000,000 7.700% | 5,000,000 (New Position) | Filing History |
| 2024-02-14 4:30 pm Purchase | 2024-02-07 | 13G | Adverum Biotechnologies, Inc. ADVM | Vivo Opportunity Fund Holdings L.P. | 1,500,000 7.200% | 1,500,000 (New Position) | Filing History |
| 2024-02-13 5:05 pm Sale | 2023-12-31 | 13G | Clene Inc. CLNN | Vivo Opportunity Fund Holdings L.P. | 625,000 7.000% | -261,890 (-29.53%) | Filing History |
| 2024-02-13 5:00 pm Sale | 2023-12-31 | 13G | Delcath Systems, Inc. DCTH | Vivo Opportunity Fund Holdings L.P. | 2,708,579 9.990% | -2,172,162 (-44.50%) | Filing History |
| 2024-02-13 5:00 pm Unchanged | 2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL | Vivo Opportunity Fund Holdings L.P. | 38,152,030 7.700% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:00 pm Unchanged | 2023-12-31 | 13G | Rezolute, Inc. RZLT | Vivo Opportunity Fund Holdings L.P. | 3,242,842 8.200% | 0 (Unchanged) | Filing History |
| 2023-10-13 4:30 pm Purchase | 2023-10-05 | 13G | Rezolute, Inc. RZLT | Vivo Opportunity Fund Holdings L.P. | 3,242,842 8.800% | 3,242,842 (New Position) | Filing History |
| 2023-10-11 4:30 pm Unchanged | 2023-10-02 | 13D | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings L.P. | 8,418,093 30.500% | 0 (Unchanged) | Filing History |
| 2023-08-25 4:31 pm Purchase | 2023-08-18 | 13G | COMPASS Pathways plc CMPS | Vivo Opportunity Fund Holdings L.P. | 3,216,000 5.100% | 3,216,000 (New Position) | Filing History |
| 2023-08-18 4:56 pm Purchase | 2023-08-10 | 13G | Gracell Biotechnologies Inc. GRCL | Vivo Opportunity Fund Holdings L.P. | 38,152,030 7.800% | 38,152,030 (New Position) | Filing History |
| 2023-07-14 4:30 pm Purchase | 2023-07-11 | 13G | Unicycive Therapeutics, Inc. UNCY | Vivo Opportunity Fund Holdings L.P. | 59,961,729 9.990% | 59,961,729 (New Position) | Filing History |